TrialInflammatory bowel diseases2023

Induction and Maintenance Treatment With Upadacitinib Improves Health-Related Quality of Life in Patients With Moderately to Severely Active Ulcerative Colitis: Phase 3 Study Results.

Julian Panés et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.